trial · primary record
Autologous total tumor mRNA and pp65 full length (fl) lysosomal associated membrane protein (LAMP) mRNA loaded DOTAP liposome vaccine administered intravenously (RNA loaded lipid particles, RNA-LPs)
Adult Glioblastoma
| Phase | Phase 1 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 28 |
| Primary completion | 2029-07-01 |
| Primary endpoint | Manufacturing feasibility |
| Registry ID | NCT04573140 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:40:37.149Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04573140
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.